No. MVP055/2020 August 13, 2020 Subject: Management Discussion and Analysis for the three – month and six- month periods ended 30 June 2020 To: President and Manager The Stock Exchange of Thailand M
. 004 / 2021 March 1, 2021 Subject Explanation of the operating performance for the year 2020 To Managing Director The Stock Exchange of Thailand Pan Asia Footwear Public Company Limited would like to
-TRANSLATION- 15 May 2020 Subject : Management Discussion and Analysis for Q1/2020 Attention : President The Stock Exchange of Thailand An overview of the results in the passing The performance in
-TRANSLATION- 14 August 2020 Subject : Management Discussion and Analysis for Q2/2020 Attention : President The Stock Exchange of Thailand An overview of the results in the passing The performance in
No. MVP067/2020 November 16, 2020 Subject: Management Discussion and Analysis for the three – month and nine – month periods ended September 30, 2020 To: President and Manager The Stock Exchange of
www.interpharma.co.th IP_OCS/010/2562 November 10, 2019 Subject Management’s discussion and analysis for the third quarter of 2019 To President The Stock Exchange of Thailand Interpharma Public Company Limited (“the
results for the nine-month period of 2019, change of rate more than 20 percent Dear Director and Manager The Stock Exchange of Thailand According to the resolution of the Board of Directors of DOD Biotech
(Ending September 30, 2019) To Director and Manager of the Stock Exchange of Thailand Ubis (Asia) Public Company Limited (“the Company”) would like to clarify on the performance and the financial for Q3
recorded 2,579.1 Million Baht, increasing by 45.4% as compared to Q2 2016 of 1,773.3 Million Baht. This was mainly due to the increasing revenue from property business, specifically The Ritz-Carlton